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Objective: Recently, CT arthrography (CTa) was introduced as a non-destructive technique to quantita-
tively measure cartilage quality in human knees. This study investigated whether this is also possible
using lower radiation dose CT protocols. Furthermore, we studied the ability of (lower radiation) CTa
to distinguish between local sulphated glycosaminoglycan (sGAG) content differences.
Design: Of ten human cadaveric knee joints, six CT scans using different radiation doses (81.33e8.13 mGy)
were acquired after intra-articular ioxaglate injection. The capability of CTa to measure overall cartilage
quality was determined in seven anatomical regions of interest (ROIs), using equilibrium partitioning of an
ionic contrast agent using (EPIC)-microCT (mCT) as reference standard for sGAG content. To test the
capability of CTa to spatially distinguish between local differences in sGAG content, we calculated the
percentage of pixels incorrectly predicted as having high or low sGAG content by the different CTa
protocols.
Results: Low radiation dose CTa correlated well with EPIC-mCT in large ROIs (R ¼ 0.78; R2 ¼ 0.61;
P < 0.0001). CTa can also distinguish between high and low sGAG content within a single slice. However,
the percentage of incorrectly predicted quality pixels increases (from 35% to 41%) when less radiation is
used. This makes is hard or even impossible to differentiate between spatial differences in sGAG content
in the lowest radiation scans.
Conclusions: CTa acquired using low radiation exposure, comparable to a regular knee CT, is able to
measure overall cartilage quality. Spatial sGAG distribution can also be determined using CTa, however
for this purpose a higher radiation dose is necessary. Nevertheless, radiation dose reduction makes CTa
suitable for quantitative analysis of cartilage in clinical research.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The current reference standard for grading the severity of
osteoarthritis (OA) in the knee is the radiography based Kellgren
and Lawrence score1. This technique is, however, not sensitive
enough to detect or follow OA at an early stage of the disease
because it only indirectly visualizes the cartilage and is not able
to (semi)quantitatively measure cartilage quality2. Therefore,: J. van Tiel, Department of
x 2040, 3000 CA Rotterdam,
4690.
l).
s Research Society International. Psophisticated magnetic resonance imaging (MRI) imaging tech-
niques have been developed which can qualitatively measure
cartilage quality in terms of the sulphated glycosaminoglycan
(sGAG), collagen or sodium content of articular cartilage3e5.
Recently, it has been shown that CT arthrography of the knee
(CTa) is able to measure overall cartilage quality in large anatomical
cartilage regions in human cadaveric knees6. Similar to microCT
(mCT) arthrography in small animals7,8 and delayed gadolinium
enhanced MRI of cartilage (dGEMRIC) in humans9e11, this tech-
nique uses the inversed relationship between a negatively charged
contrast agent (ioxaglate) and the sGAG content of cartilage.
The reported CTa protocol has a CT-Dose Index (CTDIvol) of
81.33 mGy per CTa scan, which poses a limitation on this tech-
nique12. Therefore, the radiation dose must be reduced before CTa
can be used in clinical research. The use of less radiation to acquireublished by Elsevier Ltd. All rights reserved.
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structed CT images. This increase of noise may inﬂuence the
measured X-ray attenuation values and therefore interfere with the
capability of measuring quality of cartilage using CTa.
Therefore, we designed a cadaver study with the purpose to
investigate the effect of radiation dose reduction of CTa on its ability
to measure articular cartilage quality in large cartilage regions. We
also assessed the capability of CTa to distinguish between spatial
high and low sGAG content of cartilage on a single slice and the
inﬂuence of radiation dose reduction on this capability. The latter is
of interest because it could enable the use of CTa as a tool to




For this study, we used ten randomly selected cadaveric lower
extremities from eight individuals who had donated their bodies to
science. All extremities were frozen at 20C directly after death.
Before the start of the experiment, the specimens were defrosted
slowly in a cooled environment (7C) for 5 days. All extremities
were at room temperature during imaging procedures.
Acquisition and post-processing of CTa data
We injected 20 mL of 30% ioxaglate dilution (Hexabrix 320,
Mallinckrodt, Hazelwood, MO, USA and saline) intra-articularly in
all knee joints, using an 18 gauge needle. After the injection, we
ﬂexed (w120) and extended (w0) the knee joints for 5 min in
order to achieve optimal distribution of the contrast agent
throughout the joint cavity. Ten minutes after contrast injection,
CTa scans of all knee joints were acquired using a second gener-
ation dual source multidetector spiral CT scanner (SOMATOM
Deﬁnition Flash, Siemens Healthcare AG, Erlangen, Germany)
with a tube voltage of 80 kV, an effective mAs value of 3,140 mAs,
a pitch of 0.35 and a collimation of 32  0.6 mm, resulting in a
CTDIvol of 81.33 mGy6. This protocol will be referred to as
maximum dose in this paper. Directly after the ﬁrst scan, ﬁve
additional scans were acquired using the same tube voltage
(80 kV), but with reduced radiation exposures: 1,570 mAs (50%),
1,256 mAs (40%), 942 mAs (30%), 628 mAs (20%) and 314 mAs
(10%) per scan. All knee joints were scanned in the axial plane
with a scanning time of 30 s per scan. All CT datasets were
reconstructed with an effective slice thickness of 0.75 mm and
a sharp reconstruction kernel. Multiplanar reconstruction was
performed (image pixel size 0.265 mm).Fig. 1. 3D representation of the seven analyzed large cartilage ROIs per kUsing Skyscan analysis software (Skyscan, Kontich, Belgium), we
segmented all CT datasets into binary datasets using one ﬁxed
attenuation threshold of 500 Hounsﬁeld units (HU) that was
selected because it resulted in the best segmentation of the carti-
lage6. Next, we manually deﬁned seven anatomical cartilage
regions of interest (ROIs) in all CT datasets based on the nomen-
clature and scheme as suggested by Eckstein et al.13. Each ROI
consisted of 40 consecutive slices covering the central weight-
bearing area of the cartilage of both the medial and lateral femoral
condyles (wbMC and wbLC), the posterior non-weight bearing
cartilage area of both femoral condyles (pMC and pLC), both
weight-bearingmedial and lateral tibial plateaus (wbMP andwbLP)
and the mid-portion of the patellar cartilage (mpP) [Fig. 1(AeC)].
After deﬁning all ROIs, we calculated the mean X-ray attenuation
per cartilage ROI on the CTa scans.
Equilibrium partitioning of an ionic contrast agent using (EPIC)-mCT
Mean X-ray attenuation values of EPIC-mCT have a good corre-
lation with the sGAG content of articular cartilage measured with
a dimethylmethylene blue essay or quantiﬁed with optical density
measurements14e16. Therefore, we selected the outcomes of EPIC-
mCT in mean X-ray attenuation values as our reference test of sGAG
content of articular cartilage.
After CTa, all knee joints were dissected into ﬁve parts: the
medial and lateral femoral condyles, the medial and lateral tibial
plateaus and the patella. Soft tissue was removed to a maximal
extent, without harming the integrity of the cartilage. In order to
achieve equilibrium between the contrast agent and the sGAG
content of the cartilage, all dissected specimens were incubated in
an ioxaglate dilution (Hexabrix 320, Mallinckrodt, Hazelwood, MO,
USA and saline) for 24 h at room temperature17e19. We used a 20%
dilution of ioxaglate, which resulted in the best cartilage segmen-
tation at the air/cartilage and bone/cartilage interfaces6.
mCT scans were performed on a Skyscan 1076 in vivo mCT scanner
(Skyscan, Kontich, Belgium). The following scan settings were used:
isotropic voxel size of 35 mm; a voltage of 55 kV; a current of
181mA; ﬁeld of view 68mm; a 0.5 mm aluminium ﬁlter; 198 with
a 0.4 rotation step6. Scanning time per specimen was 6e10 h,
depending on the size of the specimen (patella, plateau or
condyle). A plastic foil was wrapped around the specimen to
avoid dehydration during scanning. All scans were performed
using the same settings and all data were reconstructed identically.
Using Skyscan analysis software, we segmented the mCT data-
sets using a ﬁxed attenuation threshold between air and sub-
chondral bone that was selected visually for the best segmentation
result in all datasets6. In all segmented mCT datasets, seven
anatomical ROIs of the cartilage corresponding with ROIs of the CTanee joint: (A) pMC/pLC; (B) wbMC/wbLC; (C) wbMP/wbLP and mpP.
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was calculated.
Spatial analysis of cartilage quality
Using commercially available software (Matlab version 7.1,
MathWorks, Natick, MA, USA and Multimodality Image Registra-
tion using Information Theory (MIRIT), Laboratory for Medical
Imaging Research, Leuven, Belgium20), all CTa (50%, 40%, 30%, 20%
and 10%) and EPIC-mCT datasets were registered using the dataset
that was acquired at the maximum dose as reference. Registration
of the datasets enabled comparison of corresponding cartilage
regions (femoral condyles, tibial plateaus and patellar cartilage) in
all CTa scans per knee.
To study the capability of CTa to analyze the spatial distribution
of high and low sGAG content in cartilage and the inﬂuence of
radiation dose reduction on this capability, we used the EPIC-mCT
as reference standard for spatial sGAG distribution in cartilage
[Fig. 2(A)]14e16. Using Skyscan analysis software, we deﬁned an area
of high and low sGAG content in the cartilage within a central slice
through the medial and lateral tibiofemoral joint and on a central
slice of the mpP in all CTa datasets (maximum dose, 50%, 40%, etc.)
[Fig. 2(BeD)]. To deﬁne these areas (which wewill refer to as masks
from now on), we used 150 HU as cut-off point between high and
low sGAG content of cartilage. We used this number based on the
point where the cumulative histogram of all cartilage ROIs used inFig. 2. EPIC-mCT datasets are used as reference for the spatial sGAG distribution of cartilag
maximum radiation dose shown), a mask for high and low sGAG content was created (C, D).
mCT images, the number of pixels correctly and incorrectly predicted as having a high and lowthe spatial analysis of cartilage reaches 50% (supplementary Fig. 1).
Next, both masks for sGAG distribution were used as an overlay
for cartilage on the registered corresponding EPIC-mCT images
[Fig. 2(E, F)]. Within the masked EPIC-mCT images, we calculated
the number of pixels deﬁned as having high or low sGAG content by
CTa, using a threshold of 70 gray values for EPIC-mCT. This was again
based on the cumulative histogram of all cartilage ROIs on the
EPIC-mCT images (supplementary Fig. 1). Finally, we calculated the
number of pixels which were incorrectly deﬁned as high or low
quality by CTa by adding the number of incorrectly deﬁned pixels in
both masks, dividing them by the total number of pixels in both
masks together and then multiplying them by 100 to obtain the
percentage of incorrectly deﬁned pixels [Fig. 2(G, H)].
Statistical analysis
In this study we used ten knees from eight individuals. The use
of two knees from one individual could potentially lead to an
overestimation of the correlation between mCT and CTa measure-
ments21,22. Exclusion of either one of the knees in the two patients
that were scanned bilaterally did not inﬂuence the results of our
study. Therefore, we decided to exclude the bilaterally scanned
knees from the analysis.
The correlation between the mean X-ray attenuation values of
CTa and the mean X-ray attenuation values of EPIC-mCT was
calculated per radiation dose for all cartilage ROIs pooled. Becausee (A). Using a ﬁxed X-ray attenuation threshold of 150 HU in all CTa datasets (B, only
The masks were used as an overlay of EPIC-mCT cartilage (E, F). Within the masked EPIC-
sGAG content by CTa was calculated (G, H). #: high sGAG content. *: low sGAG content.
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the potential correlation which might already exist within all knee
joints itself, we used a linear mixed model to analyze if the corre-
lation coefﬁcients between, CTa outcomes and EPIC-mCT outcomes
were statistically signiﬁcant.
All analyses were performed using GraphPad (Graphpad Soft-
ware Inc., San Diego, USA) and SPSS version 17.0 (SPSS Inc., Chicago,




After CT scanning, four knees were excluded from the study due
to clearly visible calciﬁcations in the cartilage anddue to the fact that
from two individuals two knees were scanned. Thus, a total of six
cadaveric knee joints from six individuals were included in the
analysis (three female, three male; mean age at death 72 years; ageFig. 3. Correlation plots of mean attenuation from EPIC-mCT and CTa acquired using six dif
radiation dose (n ¼ 33); C: 40% of the maximum radiation dose (n ¼ 33); D: 30% of the maxim
the maximum radiation dose (n ¼ 33). The dashed lines indicate the 95% conﬁdence intervrange at death 30e94 years). Furthermore,12 cartilage ROIswere not
included in our data analysis because of motion artifacts during mCT
scanning and segmentation errors due to severe cartilage loss8.
Correlation of CTa with sGAG content in large anatomical ROIs
Mean X-ray attenuation values of the CTa scans acquired with
maximum radiation correlated strongly with the sGAG content of
cartilage expressed by EPIC-mCT attenuation values (n ¼ 33;
R ¼ 0.81; R2 ¼ 0.66; P < 0.0001) [Fig. 3(A)]. In the analysis of the
additional CTa scans with reduced radiation dose, this correlation
remained strong when radiation dose was reduced; 50% of the
maximum radiation dose (n ¼ 33; R ¼ 0.78; R2 ¼ 0.60; P < 0.0001),
40% of the maximum radiation dose (n ¼ 33; R ¼ 0.76; R2 ¼ 0.58;
P < 0.0001), 30% of the maximum radiation dose (n ¼ 33; R ¼ 0.76;
R2¼ 0.59; P< 0.0001), 20% of themaximum radiation dose (n¼ 33;
R¼ 0.77; R2¼ 0.59; P< 0.0001), and 10% of the maximum radiation
dose (n ¼ 33; R ¼ 0.78; R2 ¼ 0.61; P < 0.0001) radiation dose per
scan was used [Fig. 3(BeF)].ferent radiation doses. A: maximum radiation dose (n ¼ 33); B: 50% of the maximum
um radiation dose (n ¼ 33); E: 20% of the maximum radiation dose (n ¼ 33); F: 10% of
al of the best ﬁt regression line.
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The number of pixels that were incorrectly deﬁned as having
high or low sGAG content by CTa was lowest in the CTa scan
acquired using the maximum radiation dose (35%  9%) (Fig. 4).
When less radiation was used to obtain CTa, the number of pixels
which were incorrectly deﬁned as high and low quality cartilage
increased (50% radiation: 37%  9%, 40% radiation: 38%  9%, 30%
radiation: 38%  9%, 20% radiation: 39%  9%, 10% radiation:
40%  9%) (Fig. 4). The effect of this increase in incorrectly deﬁned
pixels on the capability of CTa to distinguish between the spatial
distribution of high and low sGAG content of cartilage within
a single slice is clearly visible in Fig. 5.Discussion
Recently, CTa was introduced as a non-destructive method to
measure cartilage quality in human cadaveric knees6. The main aim
of the present cadaver study was to assess whether radiation dose
reduction inﬂuences the ability of CTa to measure cartilage quality.
Lowering the ionizing radiation dose of the acquisition protocol is
necessary to make CTa suitable and acceptable for use in clinical
research in humans. The results of this study demonstrate that
mean attenuation values in large anatomical ROIs in CTa acquired
with different radiation doses are strongly correlated with the
sGAG content of articular cartilage measured with EPIC-mCT. This
correlation was similar to previous reported results in cadavers6
and also similar to previously published in vitro results15,18,23.
When the radiation dose used to acquire CT scans was decreased,
the correlation between CTa X-ray attenuation values and the sGAG
content of cartilage only slightly decreased, but remained good,
even if the radiation dose was reduced to approximately 10% of the
original dose. The correlation between X-ray attenuation and the
reference test for sGAG content remains relatively good because
of the fact that the noise in the CT images averages out when
calculating the mean X-ray attenuation values in relatively large
cartilage ROIs.
The second aim of this study was to assess the capability of CTa
to detect local differences in the sGAG content of articular cartilage
and to study the effect of radiation dose reduction on this differ-
entiation of cartilage quality within a single slice. The ability to
detect local differences in cartilage sGAG content could make CTa
applicable as a diagnostic tool for focal cartilage damage instead of
a diagnostic arthroscopy. Additionally, it would enable the use of
CTa as an imaging tool to measure the effect of cartilage repairFig. 4. Bar graphs showing the percentage of pixels incorrectly predicted as high and
low sGAG content by the different radiation doses (maximum, 50%, 40%, 30%, 20% and
10% of the maximum dose) used in this study. Whiskers show the 95% conﬁdence
interval of the mean.therapies (e.g., microfracturing and autologous chondrocyte
implantation24,25) similar to MRI based techniques like dGEM-
RIC26,27. Our results demonstrate that, using CTa acquired using the
maximum radiation dose, high and low sGAG distribution can be
clearly distinguished. An important remark is that the choice of the
used thresholds for deﬁning high and low sGAG content within the
cartilage based on the pooled cumulative histograms has an arbi-
trary component. This might introduce an over or underestimation
of the capability of CTa to determine local sGAG differences. The
increase of noise in the CT image obtained using lowered radiation
doses, however, causes an increased percentage of incorrectly
deﬁned pixels with high and low sGAG content. In the lowest
radiation dose used to obtain CTa, the increased noise evenmakes it
impossible to distinguish differences in sGAG distribution from
noise in the CT images.
Based on the results of this study, we suggest using a CTa
protocol with a low radiation dose if overall cartilage quality is of
interest in clinical research. The lowest radiation dose we used
(CTDIvol of 8.13 mGy per scan) is comparable to the dose of
a regular CT scan of the knee (CTDIvol of approximately 8 mGy12).
In addition to cartilage quality, morphological abnormalities can
also be diagnosed using CTa with accuracy comparable to
conventional MRI sequences. This was demonstrated in previous
research by De Filippo et al. and Vande Berg et al.28,29, however, we
did not investigate this in the present study. If the spatial distri-
bution of sGAG on a single slice is of interest, we recommend
using a higher radiation dose than for overall cartilage quality
measurements since decrease in contrast to noise ratio increases
the number of incorrectly predicted quality pixels and makes it
hard or impossible to differentiate high from low quality cartilage
at low radiation dose scans.
Despite the promising results, a limitation of CTawill remain the
use of ionizing radiation, because of the risk of predisposing
patients to the development of certain cancers by using (repetitive)
CT scans12. Therefore, MRI based techniques which quantitatively
measure cartilage quality (e.g., dGEMRIC, Na23 mapping, T2
mapping, and T1rho4,5) remain favourable in a clinical research
setting in large cohorts in humans. However, we think that by using
a relatively low radiation dose protocol, subgroups of patients in
which CTa is favourable of MRI can be identiﬁed (e.g., patients with
contra-indications to undergo MRI). In addition, CT has also some
advantages over MRI (e.g., relative short acquisition time and low
costs). Therefore, we expect that low radiation dose CTa can
become a complementary technique to MRI based techniques to
quantitatively measure cartilage quality in clinical research. In
addition to ionizing radiation, other potential limitations of CTa
when applied in humans are: the risk of infection and pain due to
the intra-articular injection with contrast agent, and the risk of an
(allergic) reaction to the contrast agent.
Future research using CTa should focus on implementing and
validating CTa in a clinical research setting in humans in vivo using
a low radiation dose protocol. Filtering the CT data using a low-pass
image processing ﬁlter will diminish the amount of noise in CT
images and might enable the use of even less radiation than sug-
gested in our study. A drawback of using such a ﬁlter is, however,
the decrease in spatial resolution of the CT images. Another method
to lower the radiation dose is the use of an iterative reconstruction
algorithm30,31 instead of the standard ﬁltered back projection
image reconstruction algorithm as used in this study. Because of
the high in plane resolution of CT images acquired with multi-
detector CT scanners, future research could also focus on investi-
gating the potential of CTa to detect subchondral bone changes and
changes in cartilage quality simultaneously. Recently, the feasibility
of contrast-enhanced peripheral quantitative CT to analyze carti-
lage and subchondral bone status on a single scan in vitro was
Fig. 5. Registered images of both EPIC-mCT and CTa acquired using different radiation doses (maximum radiation dose, 50%, 40%, 30%, 20% and 10% of the maximum radiation dose)
per scan. The attenuation of cartilage regions is visualized in colour and representative for the sGAG content of the cartilage. High attenuation values represent low sGAG content
and low attenuation values represent high sGAG content.
J. van Tiel et al. / Osteoarthritis and Cartilage 20 (2012) 678e685 683described32 and therefore it is of interest to test this as well as
in vivo using CTa.
In conclusion, CTa acquired using a low radiation dose is able to
measure overall articular cartilage quality throughout the whole
human knee with a radiation dose comparable to a regular CT scanof the knee. Spatial sGAG distribution assessment is also possible
using CTa, however for this purpose a higher radiation dose is
necessary. Nevertheless, due to the reduction in radiation dose, CTa
might be implemented as a non-destructive tool to quantitatively
measure articular cartilage in clinical research.
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